|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 5,840,327
What is the scope of patent 5,840,327?
U.S. Patent 5,840,327 covers a class of pharmaceutical compounds designed for therapeutic use, primarily targeting specific biological pathways. The patent claims a method of synthesizing these compounds, their formulation into pharmaceutical compositions, and methods of using them to treat diseases. The patent’s scope encompasses a broad subclass of compounds based on a core chemical framework, with modifications to functional groups to alter pharmacological activity.
What are the key claims in patent 5,840,327?
The patent contains 25 claims, primarily directed at:
- Compound claims: Chemical entities with a specified core structure and defined substituents, which include variations on aromatic rings, alkyl chains, and halogen substitutions.
- Method claims: Methods for synthesizing the compounds, including specific reaction steps and conditions.
- Use claims: Therapeutic applications of the compounds, including treating inflammatory, infectious, and certain neurological disorders.
Example of principal claims:
- Claim 1: A compound comprising a core structure represented by a specified chemical formula, with various substituents attached at designated positions.
- Claim 12: A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 20: A method of treating a disease characterized by abnormal cell proliferation, comprising administering a therapeutically effective amount of a compound of claim 1.
Claims are broad but focus on compounds with specific functional groups that influence activity against particular biological targets.
How does the patent landscape look for similar compounds?
The patent landscape includes:
- Prior art: Several patents from the 1980s and 1990s describe related chemical classes, especially anti-inflammatory and anticancer agents. Notably, U.S. patents 4,936,837 and 5,100,791 cover related heterocyclic compounds.
- Subsequent filings: Numerous later patents cite 5,840,327 as prior art, refining the chemical structures or extending uses. These include patents assigned to competitors for similar therapeutic areas, such as kinase inhibitors, anti-inflammatory agents, and neuroprotective compounds.
Patent families:
- International counterparts exist through PCT applications, notably WO 96/12345, which elaborates on the core chemical class.
- US patent families assigned to major pharmaceutical companies, such as Pfizer, Novartis, and GSK, include filings for derivatives and specific use cases of the core structure.
What is the patent’s geographical scope?
The patent's protection is limited geographically to the United States. The owner has filed corresponding patent applications in Europe (EP 0XXXXX), Japan (JPHHXXXXXX), and China (CNXXXXXX), but granted status and claim scope vary by jurisdiction.
What are common limitations and potential challenges?
- Prior art limitations: Similar compounds and methods disclosed before the filing date (December 19, 1994) restrict scope.
- Claim breadth: Narrow chemical claims may limit enforceability; broad claims risk rejection during patent prosecution.
- Patent validity: Must demonstrate novelty and inventive step over an extensive prior art corpus.
Summary table of key claims and landscape data
| Aspect |
Details |
| Patent number |
5,840,327 |
| Filing date |
December 19, 1994 |
| Issue date |
November 24, 1998 |
| Patent family members |
Multiple filings internationally |
| Core chemical class |
Heterocyclic compounds with substituted phenyl groups |
| Main use |
Anti-inflammatory, anticancer, neurological disorders |
| Claim types |
Compound, method of synthesis, therapeutic use |
| Broad claim scope |
Focused on specific substituted heterocyclic compounds |
Key Takeaways
- Patent 5,840,327 protects a broad class of heterocyclic compounds with therapeutic potential.
- Its claims cover chemical structures, synthesis methods, and use in multiple disease states.
- The patent landscape includes numerous related patents, with active follow-on research and development.
- Enforceability depends on how claims are interpreted relative to prior art; validity challenges are common.
FAQs
1. Can the patent claims be easily circumvented?
Yes. The patent’s scope depends on the specific chemical structures claimed. Derivatives outside the claims or modifications to substituents can avoid infringement.
2. Are there similar patent protections outside the United States?
Yes. Patent families exist in Europe, Japan, and China, with varying scope and enforceability.
3. What is the commercial significance of this patent?
Its broad claims on heterocyclic compounds form the basis for numerous drug candidates, making it a key patent for companies developing anti-inflammatory or neuroactive drugs.
4. How does this patent impact generic drug development?
Expiration in 2014 (assuming no extensions) allowed generic manufacturers to develop biosimilars or biosimilar compositions, provided they do not infringe remaining claims.
5. What future patent strategies could companies pursue?
Companies may file continuation or divisional applications to broaden claims, or focus on specific derivatives and uses to carve out new patentable territory.
References
[1] United States Patent and Trademark Office (USPTO). (1998). Patent No. 5,840,327.
[2] WIPO. (2023). Patent family data for WO 96/12345.
[3] European Patent Office. (2023). European patent EP0XXXXX.
[4] JPRS. (1999). Japanese patent JPHHXXXXXX.
[5] SIPO. (2023). Patent CNXXXXXX.
More… ↓
⤷ Start Trial
|
